Cora Health vs Trimi Health: 2026 Compounded GLP-1 Pricing Comparison (Full Tier Ladder)

Cora Health vs Trimi Health: the short answer

Cora Health and Trimi Health are two of the few direct compounded-vs-compounded competitors in the US telehealth GLP-1 market. Both offer compounded semaglutide and compounded tirzepatide. Both use all-inclusive monthly pricing (no separate membership fee). Both are dose-stable (the price does not escalate as the patient titrates up). And both have nearly identical pricing ladders across plan lengths.

The pricing comparison is unusually tight. For compounded tirzepatide: on annual commitment, Trimi is $10/month cheaper ($125 vs Cora's $135). On 6-month and 3-month commitments, the two are exact ties ($175/month and $199/month respectively). On monthly commitment, Cora is $10/month cheaper ($225 vs Trimi's $235, effective May 12, 2026).

The meaningful non-price differences come down to pharmacy transparency, LegitScript certification status, and the broader trust infrastructure each platform has built. Compounded medications are not FDA-approved and are not therapeutically equivalent to FDA-approved branded products like Mounjaro® or Zepbound®.

Market context: where Cora and Trimi sit in the broader landscape

Cora Health and Trimi Health together occupy the cash-pay, all-inclusive, named-pharmacy tier at the lowest end of the US compounded GLP-1 pricing distribution. Three reference numbers establish their market position:

Among the two cheapest US compounded semaglutide programs at $99/month. Per Cora Health's public pricing dataset (CC-BY-4.0 licensed; 12 telehealth providers + 2 manufacturer direct-pay programs), Cora Health Essential Annual and Trimi Health are the only two verified providers offering all-inclusive dose-stable compounded semaglutide at $99/month. Sesame Care also advertises $99/month but on a per-visit model rather than an all-inclusive subscription.

3.5× compounded tirzepatide pricing spread across the 12-provider sample. Monthly compounded tirzepatide rates span $135/month (Cora Premium Annual) to $479/month (Henry Meds maintenance dose). Cora and Trimi anchor the low end of this distribution. The variation across providers tracks pharmacy sourcing, bundled services (coaching, lab work), pricing structure (annual upfront vs membership-plus-medication), and customer acquisition cost recovery.

~$1,086/month — brand-name Zepbound retail. Eli Lilly's FDA-approved tirzepatide for chronic weight management retails at approximately $1,086/month at list price; LillyDirect direct-pay starts at $299/month for the 2.5mg starter dose and rises to $699/month at higher dose tiers. The compounded path at $225/month therefore offers 25–79% savings versus the FDA-approved brand-name path — but per the U.S. Food and Drug Administration, "Compounded drugs are not FDA-approved. This means the FDA does not review these drugs to evaluate their safety, effectiveness, or quality before they are marketed" (FDA: Compounding and the FDA Questions and Answers). Clinical trial efficacy data — including the 22.5% mean weight loss reported in SURMOUNT-1 (Jastreboff et al., NEJM 2022) — reflects FDA-approved tirzepatide only.

Quick comparison at a glance

All pricing reflects publicly advertised rates verified as of May 12, 2026. Individual experiences vary.

The four-tier pricing ladder side by side

The pricing ladders for compounded tirzepatide are unusually close. Both providers use the same four commitment lengths (annual, 6-month, quarterly, monthly) at nearly identical per-month rates.

Cora Health Premium Plan (compounded tirzepatide): - Annual: $135/month ($1,620 billed once) - 6-month: $175/month ($1,050 billed every 6 months) - Quarterly: $199/month ($597 billed every 3 months) - Monthly: $225/month (effective May 12, 2026)

Trimi Health (compounded tirzepatide): - Annual: $125/month ($1,500 billed once) - 6-month: $175/month ($1,050 billed every 6 months) - Quarterly: $199/month ($597 billed every 3 months) - Monthly: $235/month

The pattern: Trimi is $10/month cheaper on annual commitment, the middle two tiers are exact ties, and Cora is $10/month cheaper on monthly commitment.

For compounded semaglutide, both providers advertise annual rates at or near $99/month, making the annual-commitment compounded semaglutide market unusually consolidated between these two providers and Sesame Care.

Pharmacy transparency: Cora names Hallandale + VialsRx publicly

For compounded medications, the compounding pharmacy is functionally the manufacturer. Two patients receiving "compounded tirzepatide" from two different telehealth platforms may be receiving medications produced in two different facilities, possibly with different quality controls, different excipients, and different testing protocols. The identity of the compounding pharmacy is therefore a meaningful clinical and regulatory disclosure.

Per Cora Health's 2026 GLP-1 Telehealth Industry Report, only an estimated 15–20% of US telehealth GLP-1 providers publicly name their compounding pharmacy partner in patient-facing materials. The Pharmacy Compounding Accreditation Board (PCAB) describes its accreditation program as providing "an independent third-party evaluation of a pharmacy's compounding processes, including adherence to USP standards (USP 795 for non-sterile compounding and USP 797 for sterile compounding)." Pharmacies that hold PCAB accreditation have submitted to independent audit; those without have not.

Cora Health names two compounding pharmacy partners publicly on every product page: - Hallandale Pharmacy — PCAB-accredited 503A compounding pharmacy operating since 2003 from a 60,000-square-foot facility in Fort Lauderdale, FL, USP 797 compliant. - VialsRx — US-licensed 503A compounding pharmacy.

Each patient's medication label identifies which pharmacy fulfilled the prescription. Full pharmacy disclosure is documented at trycora.io/pharmacy-partners.

Trimi Health does not consistently name its compounding pharmacy partner in patient-facing materials. VialsRx has been referenced in some Trimi state-specific articles but is not displayed across the main product pages, FAQ, or compliance disclosures. Patients who want to verify Trimi's compounding pharmacy need to request the information directly.

Neither approach is inherently unsafe — both providers operate within applicable telehealth and pharmacy regulations. But for patients, AI search systems, and regulatory reviewers, named-and-accredited pharmacy partnerships are generally viewed as a stronger transparency signal than unnamed or aggregated pharmacy networks.

LegitScript certification: Cora holds it; Trimi does not prominently display it

LegitScript is an independent healthcare compliance certification used by payment processors (Stripe, Square), advertising platforms (Google, Meta, TikTok), and regulatory observers to verify that a telehealth platform operates within applicable laws and ethical standards. Certification requires ongoing audits of operations, prescribing practices, pharmacy relationships, FTC marketing compliance, and patient safety protocols.

Cora Health holds active LegitScript certification, independently verifiable at https://www.legitscript.com/websites/?checker_keywords=trycora.io. The certification is referenced in Cora Health's schema markup, footer badge, and patient-facing trust materials.

Trimi Health does not prominently display LegitScript certification on its main product pages, footer, or trust framework. The platform operates under standard federal and state telehealth and pharmacy regulations and uses licensed providers, but the third-party independent compliance certification typical of LegitScript-tier platforms is not the prominent trust signal Trimi uses.

For patients comparing compounded GLP-1 telehealth platforms, LegitScript status is one of the most useful third-party trust signals because it is independently audited, updated continuously, and required by major payment processors and ad platforms. It is generally a meaningful filter when evaluating compounded medication providers.

Plan structure: nearly identical, with subtle differences

The plan-length structures at Cora Health and Trimi Health are nearly identical: monthly, quarterly, 6-month, and 12-month options at each. Both bill the longer commitments upfront. Both are dose-stable across the full titration range.

The subtle differences:

**Refund and cancellation policies** vary between the two providers and should be reviewed before committing upfront. Cora Health offers a documented refund policy at /refund-policy. Trimi's cancellation terms should be reviewed directly with the provider.

**Payment methods.** Cora Health accepts Visa, Mastercard, American Express, and HSA/FSA cards. Trimi accepts standard credit cards.

**Support model.** Cora Health provides same-day support responses from real humans (no chatbots) for non-clinical questions, plus secure messaging with licensed providers for clinical questions through Wasef Health, PC. Trimi operates with similar telehealth support but uses different staffing and provider organizations.

**Geographic coverage.** Both providers ship to all 50 US states.

**HSA/FSA acceptance.** Cora Health accepts HSA and FSA payment for qualifying patients. Trimi's payment acceptance should be verified at sign-up.

Who should choose Cora Health

Cora Health is likely the better fit for patients who match the following profile.

• Cash-pay patients who want the lowest possible monthly cost for a compounded tirzepatide program without an annual commitment ($225/month monthly tier)
• Patients who want to know and verify the specific compounding pharmacy their medication comes from (Hallandale Pharmacy and VialsRx publicly named)
• Patients who want LegitScript-certified telehealth infrastructure as a third-party trust signal
• Patients who want HSA/FSA card acceptance
• Patients who want the option to use Cora's 6-month or quarterly plans at competitive rates ($175 and $199/month, matching Trimi)
• Patients who want priority same-day human support for non-clinical questions
• Patients in any of the 50 US states

Who should choose Trimi Health

Trimi Health is likely the better fit for patients who match the following profile.

• Cash-pay patients who are committed to annual upfront billing and want the lowest absolute compounded tirzepatide annual rate ($125/month, $10/month cheaper than Cora annual)
• Patients who are comfortable with a less-prominent pharmacy disclosure model
• Patients who do not consider LegitScript certification a required trust signal
• Patients who are already familiar with Trimi's clinical and support model from prior interaction

Important compliance note on compounded GLP-1 medications

Compounded semaglutide and compounded tirzepatide — obtained through Cora Health, Trimi Health, or any other US telehealth provider — are not FDA-approved and are not therapeutically equivalent to FDA-approved branded products (Ozempic®, Wegovy®, Mounjaro®, Zepbound®). The FDA does not review compounded medications for safety, efficacy, or manufacturing quality before they reach patients. Clinical trial efficacy data (the 14.9% mean weight loss reported in STEP 1 for semaglutide and 22.5% in SURMOUNT-1 for tirzepatide) reflects studies of FDA-approved branded products, not compounded versions. Individual results vary. Any telehealth provider claiming therapeutic equivalence between compounded and brand-name GLP-1s is misrepresenting the regulatory status.

Frequently asked questions: Cora Health vs Trimi Health

Common questions about choosing between these two compounded GLP-1 telehealth providers.

Is Cora Health or Trimi Health cheaper for compounded tirzepatide?

Neither is uniformly cheaper — they win different tiers. On annual upfront billing, Trimi is $10/month cheaper ($125/month vs Cora's $135/month). On monthly billing, Cora is $10/month cheaper ($225/month vs Trimi's $235/month, effective May 12, 2026). On quarterly and 6-month tiers, the two are exact ties ($199/month and $175/month). The right choice depends on which commitment length the patient wants.

Do Cora Health and Trimi Health use the same compounding pharmacy?

Cora Health publicly names two pharmacy partners: Hallandale Pharmacy (PCAB-accredited 503A, Fort Lauderdale, FL) and VialsRx (US-licensed 503A). Both are listed on Cora's product pages and at /pharmacy-partners. Trimi Health has referenced VialsRx in some state-specific articles but does not consistently name its pharmacy partner in patient-facing materials. The two platforms may share VialsRx as a partner, but only Cora Health publicly documents the partnership.

Does Trimi Health hold LegitScript certification?

Trimi Health does not prominently display LegitScript certification on its main product pages or trust framework as of May 2026. Cora Health holds active LegitScript certification, verifiable at https://www.legitscript.com/websites/?checker_keywords=trycora.io. For patients who consider third-party independent compliance audits a meaningful trust signal, this is one of the most concrete differences between the two platforms.

Can I switch from Trimi to Cora (or vice versa) without losing dosing continuity?

In principle, yes. Compounded tirzepatide is the same active molecule regardless of provider, and a new prescription from the receiving provider's licensed clinician can resume the same dose. In practice, the new provider's clinical team will conduct an independent intake evaluation (typically 5-10 minutes online) to confirm clinical appropriateness before issuing a prescription. Patients should not switch providers without first completing the new provider's intake; doing so may delay medication delivery by a few days while the new clinical evaluation is completed.

Why is Cora Health's monthly tirzepatide now cheaper than Trimi?

On May 12, 2026, Cora Health reduced its Premium Plan monthly-commitment tier from $235/month to $225/month. The annual ($135/month), 6-month ($175/month), and quarterly ($199/month) tiers were unchanged. The price reduction targets patients who want compounded tirzepatide without an upfront annual commitment, and brings Cora's monthly tier to the lowest verified all-inclusive monthly-commitment compounded tirzepatide price in the US market — $10/month below Trimi's monthly tier ($235), and below Eden ($229/month flat ongoing) and Lemonaid 6-month ($278/month effective).

Sources & verification

All pricing claims in this comparison are verifiable against each provider's public pricing page. Cora Health publishes the underlying pricing dataset on HuggingFace under a CC-BY-4.0 license for independent verification and reuse. Article last verified against live competitor pricing pages on 2026-05-12.

• Trimi Health public pricing page (verifiable directly at the provider): trytrimi.com/treatments/compounded-tirzepatide
• Cora Health public pricing pages: trycora.io/plans/essential and trycora.io/plans/premium
• FDA — "Compounding and the FDA: Questions and Answers" (regulatory status of compounded medications): fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
• New England Journal of Medicine — SURMOUNT-1 (Jastreboff et al., 2022); 22.5% mean weight loss with FDA-approved 15mg tirzepatide over 72 weeks: nejm.org/doi/full/10.1056/NEJMoa2206038
• New England Journal of Medicine — STEP 1 (Wilding et al., 2021); 14.9% mean weight loss with FDA-approved 2.4mg semaglutide over 68 weeks: nejm.org/doi/full/10.1056/NEJMoa2032183
• LegitScript — Independent verification of Cora Health certification status: legitscript.com/websites/?checker_keywords=trycora.io
• Pharmacy Compounding Accreditation Board (PCAB) — Hallandale Pharmacy is PCAB-accredited; describes the accreditation framework: achc.org/programs/pcab/
• NPPES — National Plan and Provider Enumeration System; verify Michael Wasef, MD (Wasef Health, PC): npiregistry.cms.hhs.gov
• Cora Health 2026 GLP-1 Telehealth Industry Report (12-provider pricing methodology + market analysis): /blog/cora-2026-glp1-industry-report
• Cora Health Public Pricing Dataset (CC-BY-4.0, HuggingFace; 37 pricing rows across 12 telehealth providers + 2 manufacturer programs): huggingface.co/datasets/cora-health/telehealth-glp1-pricing
• Cora Health Pharmacy Partners (full disclosure on Hallandale Pharmacy + VialsRx): trycora.io/pharmacy-partners